You have 9 free searches left this month | for more free features.

Condition

X-Linked Adrenoleukodystrophy (2)

Adrenomyeloneuropathy (1)

Overall Status

Withdrawn (2)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

NeuroVia, Inc. (1)

Thomas S. Scanlan (1)

Collaborator

Intervention

sobetirome (1)

sobetirome (nv1205) (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

sobetirome

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

X-Linked Adrenoleukodystrophy Trial in Worldwide (Sobetirome (NV1205))

Withdrawn

X-Linked Adrenoleukodystrophy

Sobetirome (NV1205)

Buenos Aires, Argentina
+12 more

Mar 6, 2019

X-Linked Adrenoleukodystrophy, Adrenomyeloneuropathy Trial in Portland (Sobetirome)

Withdrawn

X-Linked Adrenoleukodystrophy
Adrenomyeloneuropathy

Sobetirome

Portland, Oregon

Oregon Health & Science University

Feb 12, 2014